Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 630.0
(-0.16%)
JPY 630.0
(-0.16%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - JPY | 0.0% |
| 2022 | - JPY | -100.0% |
| 2021 | 133 Thousand JPY | -84.78% |
| 2020 | 874 Thousand JPY | -47.91% |
| 2019 | 1.67 Million JPY | -44.91% |
| 2018 | 3.04 Million JPY | 5.29% |
| 2017 | 2.89 Million JPY | -63.37% |
| 2016 | 7.89 Million JPY | -45.76% |
| 2015 | 14.56 Million JPY | -22.16% |
| 2014 | 18.7 Million JPY | -95.72% |
| 2013 | 436.63 Million JPY | 38.93% |
| 2012 | 314.28 Million JPY | -39.8% |
| 2011 | 522.05 Million JPY | -31.69% |
| 2010 | 764.27 Million JPY | -24.24% |
| 2009 | 1 Billion JPY | 58.0% |
| 2008 | 638.45 Million JPY | 46.72% |
| 2007 | 435.15 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - JPY | 0.0% |
| 2024 Q2 | - JPY | 0.0% |
| 2023 Q1 | - JPY | 0.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 FY | - JPY | 0.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2023 Q4 | - JPY | 0.0% |
| 2022 Q4 | - JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2022 Q1 | - JPY | -100.0% |
| 2022 FY | - JPY | -100.0% |
| 2021 Q4 | 133 Thousand JPY | 0.0% |
| 2021 Q3 | - JPY | 0.0% |
| 2021 Q2 | - JPY | 0.0% |
| 2021 Q1 | - JPY | -100.0% |
| 2021 FY | 133 Thousand JPY | -84.78% |
| 2020 FY | 874 Thousand JPY | -47.91% |
| 2020 Q2 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 Q4 | 874 Thousand JPY | 0.0% |
| 2020 Q1 | - JPY | -100.0% |
| 2019 Q1 | - JPY | -100.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2019 FY | 1.67 Million JPY | -44.91% |
| 2019 Q4 | 1.67 Million JPY | 0.0% |
| 2018 FY | 3.04 Million JPY | 5.29% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q1 | - JPY | -100.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q4 | 3.04 Million JPY | 0.0% |
| 2017 Q4 | 2.89 Million JPY | 0.0% |
| 2017 FY | 2.89 Million JPY | -63.37% |
| 2017 Q3 | - JPY | 0.0% |
| 2017 Q2 | - JPY | 0.0% |
| 2017 Q1 | - JPY | -100.0% |
| 2016 FY | 7.89 Million JPY | -45.76% |
| 2016 Q2 | - JPY | 0.0% |
| 2016 Q3 | - JPY | 0.0% |
| 2016 Q4 | 7.89 Million JPY | 0.0% |
| 2016 Q1 | - JPY | -100.0% |
| 2015 Q1 | - JPY | -100.0% |
| 2015 FY | 14.56 Million JPY | -22.16% |
| 2015 Q4 | 14.56 Million JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2014 Q3 | 595.04 Million JPY | -5.52% |
| 2014 Q2 | 629.8 Million JPY | 43.07% |
| 2014 FY | 18.7 Million JPY | -95.72% |
| 2014 Q1 | 440.2 Million JPY | 0.82% |
| 2014 Q4 | 18.7 Million JPY | -96.86% |
| 2013 Q3 | 460.8 Million JPY | -4.77% |
| 2013 FY | 436.63 Million JPY | 38.93% |
| 2013 Q2 | 483.9 Million JPY | 66.96% |
| 2013 Q4 | 436.63 Million JPY | -5.24% |
| 2013 Q1 | 289.83 Million JPY | -7.78% |
| 2012 Q2 | 385.53 Million JPY | -19.15% |
| 2012 Q1 | 476.83 Million JPY | -8.66% |
| 2012 Q3 | 352.18 Million JPY | -8.65% |
| 2012 Q4 | 314.28 Million JPY | -10.76% |
| 2012 FY | 314.28 Million JPY | -39.8% |
| 2011 Q2 | 639.62 Million JPY | -11.91% |
| 2011 Q3 | 601.47 Million JPY | -5.96% |
| 2011 Q4 | 522.05 Million JPY | -13.2% |
| 2011 FY | 522.05 Million JPY | -31.69% |
| 2011 Q1 | 726.12 Million JPY | -4.99% |
| 2010 Q2 | 884.11 Million JPY | -8.91% |
| 2010 FY | 764.27 Million JPY | -24.24% |
| 2010 Q3 | 850.76 Million JPY | -3.77% |
| 2010 Q4 | 764.27 Million JPY | -10.17% |
| 2010 Q1 | 970.61 Million JPY | -3.78% |
| 2009 Q4 | 1 Billion JPY | -8.3% |
| 2009 Q2 | 1.13 Billion JPY | -0.13% |
| 2009 Q1 | 1.13 Billion JPY | 77.76% |
| 2009 Q3 | 1.1 Billion JPY | -2.94% |
| 2009 FY | 1 Billion JPY | 58.0% |
| 2008 Q4 | 638.45 Million JPY | 65.06% |
| 2008 FY | 638.45 Million JPY | 46.72% |
| 2008 Q3 | 386.8 Million JPY | 0.0% |
| 2007 FY | 435.15 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | 100.0% |
| PRISM BioLab Co.,LTD | - JPY | NaN% |
| GNI Group Ltd. | 2 Billion JPY | 100.0% |
| Linical Co., Ltd. | 1.49 Billion JPY | 100.0% |
| Trans Genic Inc. | 1.32 Billion JPY | 100.0% |
| MEDINET Co., Ltd. | 781 Thousand JPY | 100.0% |
| Soiken Holdings Inc. | - JPY | NaN% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 100.0% |
| AnGes, Inc. | 214.94 Million JPY | 100.0% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | 100.0% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 100.0% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | 100.0% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 100.0% |
| Carna Biosciences, Inc. | 28.4 Million JPY | 100.0% |
| CanBas Co., Ltd. | - JPY | NaN% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 100.0% |
| RaQualia Pharma Inc. | 39.05 Million JPY | 100.0% |
| Chiome Bioscience Inc. | - JPY | NaN% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 100.0% |
| PeptiDream Inc. | 19.63 Billion JPY | 100.0% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | 100.0% |
| Ribomic Inc. | - JPY | NaN% |
| SanBio Company Limited | 397 Million JPY | 100.0% |
| Healios K.K. | 450 Million JPY | 100.0% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | NaN% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | NaN% |
| Delta-Fly Pharma, Inc. | - JPY | NaN% |
| StemRIM | - JPY | NaN% |
| CellSource Co., Ltd. | 77.29 Million JPY | 100.0% |
| FunPep Company Limited | - JPY | NaN% |
| Kringle Pharma, Inc. | - JPY | NaN% |
| Stella Pharma Corporation | 773.29 Million JPY | 100.0% |
| TMS Co., Ltd. | - JPY | NaN% |
| Noile-Immune Biotech Inc. | - JPY | NaN% |
| Cuorips Inc. | - JPY | NaN% |
| K Pharma,Inc. | - JPY | NaN% |
| Takara Bio Inc. | 788 Million JPY | 100.0% |
| ReproCELL Incorporated | - JPY | NaN% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | 100.0% |
| StemCell Institute Inc. | 6.67 Million JPY | 100.0% |
| CellSeed Inc. | 143.75 Million JPY | 100.0% |